The Journal of Pediatrics
Volume 142, Issue 6 , Pages 611-616 , June 2003

Corticosteroids in the initial treatment of Kawasaki disease: Report of a randomized trial

Received 28 May 2002 ,Revised 21 November 2002 ,Accepted 14 February 2003.

References 

  1. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al.  High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055–1058
  2. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy E, et al.  The treatment of Kawasaki syndrome with intravenous gamma gobulin. N Engl J Med. 1986;315:341–347
  3. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96:1057–1061
  4. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888–893
  5. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al.  Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776–1780
  6. Lentsch AB, Ward PA. Regulation of inflammatory vascular damage. J Pathol. 2000;190:343–348
  7. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175–179
  8. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465–469
  9. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr. 2000;137:723–726
  10. Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease. In:  Kato H editors. Kawasaki disease. Amsterdam (The Netherlands): Elsevier Science; 1994;
  11. Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J. 1982;46:1239–1242
  12. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1998;128:146–149
  13. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int. 2001;43:211–217
  14. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatr. 2000;105:E78
  15. Dahlem PG, von Rosenstiel IA, Lam J, Kuijpers TW. Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease. Intensive Care Med. 1999;25:1137–1139
  16. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222
  17. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 2000;133:254–258
  18. Barron KS, Shulman ST, Rowley A, Taubert K, Myones BL, Meissner HC, et al.  Report of the National Institutes of Health Workshop on Kawasaki disease. J Rheumatol. 1999;26:170–190
  19. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int. 2001;43:211–217
  20. Baylis EM, Williams IA, English J, Marks V, Chakraborty J. High-dose intravenous methylprednisolone “pulse” therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function. Eur J Clin Pharmacol. 1982;21:385–388
  21. Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ, et al.  Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum. 1996;39:1970–1979
  22. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992;89:9991–9995
  23. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, et al.  Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum. 1997;40:1400–1408
  24. Watanabe S, Nishiyama M, Shimizu J. Re-evaluation study in Kawasaki disease patients without coronary arterial lesions. In:  Kato H editors. Kawasaki disease. Amsterdam (The Netherlands): Elsevier; 1995;p. 619–623
  25. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–1639
  26. Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr. 1986;108:388–392
  27. Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr. 1994;124:721–725
  28. Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al.  Coronary risks after high-dose gamma-globulin in children with Kawasaki disease. Pediatr Int. 2000;42:464–469

☆ Supported in part by the Kobren Fund.

☆☆ The study sponsors had no role in study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.

★ Reprint requests: Robert P. Sundel, MD, Rheumatology Program, Children's Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail: Robert.Sundel@tch.harvard.edu.

PII: S0022-3476(03)00117-3

doi: 10.1067/mpd.2003.191

The Journal of Pediatrics
Volume 142, Issue 6 , Pages 611-616 , June 2003

Article Tools

* Image Usage & Resolution